|
ENDO PHARM HLDGS, (ENDP) Stock Research Free Stock Rating
|
|
| |
| Company Profile |
| |
|
Endo Pharmaceuticals Holdings, Inc., through its wholly owned subsidiary, Endo Pharmaceuticals, Inc., engages in the research, development, marketing, and sale of branded and generic pharmaceutical products primarily used to treat and manage pain in the United States. The companys branded products include Lidoderm, Percocet, Percodan, Frova, DepoDur, and Zydone. Lidoderm is a topical patch product containing lidocaine for the relief of the pain from post-herpetic neuralgia. Percocet and Percodan are used for the treatment of moderate-to-severe pain. Frova used for prevention of menstrually related migraine. DepoDur used for the treatment of pain following major surgery. Zydone tablets are also used for the relief of moderate-to-severe pain and contain hydrocodone/acetaminophen. The companys generic products comprise morphine sulfate, generic oxycodone hydrochloride, and acetaminophen product, which focus on pain management. It also offers Sinemet for the treatment of the symptoms of idiopathic Parkinsons disease. In addition, the company is developing products for the acute, chronic, and neuropathic pain conditions, as well as in complementary therapeutic areas. It sells its products to pharmacy chains and wholesale drug distributors who, in turn, supply products to pharmacies, hospitals, governmental agencies, and physicians. The company has strategic alliance with SkyePharma, Inc. and SkyePharma Canada, Inc. Endo was incorporated in 1997 and is headquartered in Chadds Ford, Pennsylvania.
|
|
